An in-person Stanford symposium highlighting recent progress in brain resilience and aging research, followed by a neuroscience poster session featuring work from the Stanford community.
In Neuroscience and Gerontology
Using Neighborhood Data in Aging Research: The National Neighborhood Data Archive (NaNDA)
Wed, Oct 7, 2026
Neighborhood conditions influence health and aging, but researchers can face difficulties finding contextual measures and combining them with their own studies. This practical workshop introduces NaNDA, a free archive of neighborhood measures covering the United States over several decades. Participants will work through dataset selection, geographic identifiers, matching time periods, and linkage to survey or administrative data. The programme includes a repository tour, aging-research examples, beginner and intermediate breakout groups, and discussion of participants’ data-linkage questions.
Parallel Squared Technology Institute is recruiting research associate and senior research associate candidates to operate and maintain mass spectrometers, prepare protein samples, manage reagents and samples, and analyze experimental data. The institute is developing high-throughput protein-analysis technology with initial applications in Alzheimer’s disease and aging.
How Intermittent Bioenergetic Challenges Enhance Brain and Body Health
Mark Mattson · Johns Hopkins University School of Medicine
Tue, Sep 26, 2023 · 15:00 UTC
Humans and other animals evolved in habitats fraught with a range of environmental challenges to their bodies and brains. Accordingly, cells and organ systems possess adaptive stress-responsive signaling pathways that enable them to not only withstand environmental challenges, but also to prepare for future challenges and function more efficiently. These phylogenetically conserved processes are the foundation of the hormesis principle in which repeated exposures to low to moderate amounts of an environmental challenge improve cellular and organismal fitness. Here I describe cellular and molecu
Establishment and aging of the neuronal DNA methylation landscape in the hippocampus
Sara Zocher, PhD · German Center for Neurodegenerative Diseases (DZNE), Dresden
Wed, Apr 12, 2023 · 17:00 UTC
The hippocampus is a brain region with key roles in memory formation, cognitive flexibility and emotional control. Yet hippocampal function is impaired severely during aging and in neurodegenerative diseases, and impairments in hippocampal function underlie age-related cognitive decline. Accumulating evidence suggests that the deterioration of the neuron-specific epigenetic landscape during aging contributes to their progressive, age-related dysfunction. For instance, we have recently shown that aging is associated with pronounced alterations of neuronal DNA methylation patterns in the hippoca
Neuromodulation of sleep integrity
Luís de Lecea · Stanford University
Tue, Apr 12, 2022 · 15:00 UTC
The arousal construct underlies a spectrum of behaviors that include sleep, exploration, feeding, sexual activity and adaptive stress. Pathological arousal conditions include stress, anxiety disorders, and addiction. The dynamics between arousal state transitions are modulated by norepinephrine neurons in the locus coeruleus, histaminergic neurons in the hypothalamus, dopaminergic neurons in the mesencephalon and cholinergic neurons in the basal forebrain. The hypocretin/orexin system in the lateral hypothalamus I will also present a new mechanism underlying sleep fragmentation during aging.
Multi-modal biomarkers improve prediction of memory function in cognitively unimpaired older adults
Alexandra N. Trelle · Stanford
Tue, Mar 22, 2022 · 11:00 UTC
Identifying biomarkers that predict current and future cognition may improve estimates of Alzheimer’s disease risk among cognitively unimpaired older adults (CU). In vivo measures of amyloid and tau protein burden and task-based functional MRI measures of core memory mechanisms, such as the strength of cortical reinstatement during remembering, have each been linked to individual differences in memory in CU. This study assesses whether combining CSF biomarkers with fMRI indices of cortical reinstatement improves estimation of memory function in CU, assayed using three unique tests of hippocamp
Biopsychosocial pathways in dementia inequalities
Laura Zahodne · Psychology, University of Michigan
Mon, Mar 21, 2022 · 07:00 UTC
In the United States, racial/ethnic inequalities in Alzheimer's disease and related dementias persist even after controlling for socioeconomic factors and physical health. These persistent and unexplained disparities suggest: (1) there are unrecognized dementia risk factors that are socially patterned and/or (2) known dementia risk factors exhibit differential impact across social groups. Pursuing these research directions with data from multiple longitudinal studies of brain and cognitive aging has revealed several challenges to the study of late-life health inequalities, highlighted evidence
The Role of Cerebrovascular Pathology in Aging and Neurodegenerative Disease Populations
Mahsa Dadar · Assistant Professor, Department of Psychiatry, McGill University, Canada
Wed, Feb 23, 2022 · 10:00 UTC
Late-life cognitive impairment and dementia are heterogeneous and multifactorial conditions driven by a combination of genetic, vascular, and lifestyle-related factors. More than 75% of patients with dementia have evidence of cerebrovascular pathology at autopsy. Cerebrovascular disease lesions can be detected on structural MRI and used as biomarkers to determine the extent of cerebrovascular pathology. These biomarkers are associated with cognitive difficulties and increase the risk of dementia for the same level of neurodegenerative pathology. Given that some of the risk factors for cerebrov
Neural correlates of cognitive control across the adult lifespan
Cheryl Grady
Thu, May 27, 2021 · 20:30 UTC
Cognitive control involves the flexible allocation of mental resources during goal-directed behaviour and comprises three correlated but distinct domains—inhibition, task shifting, and working memory. Healthy ageing is characterised by reduced cognitive control. Professor Cheryl Grady and her team have been studying the influence of age differences in large-scale brain networks on the three control processes in a sample of adults from 20 to 86 years of age. In this webinar, Professor Cheryl Grady will describe three aspects of this work: 1) age-related dedifferentiation and reconfiguration of
Meningeal lymphatics and peripheral immunity in brain function and dysfunction
Jonathan Kipnis · Washington University in St Louis, Missouri
Mon, Oct 5, 2020 · 15:00 UTC
Immune cells and their derived molecules have major impact on brain function. Mice deficient in adaptive immunity have impaired cognitive and social function compared to that of wild-type mice. Importantly, replenishment of the T cell compartment in immune deficient mice restored proper brain function. Despite the robust influence on brain function, T cells are not found within the brain parenchyma, a fact that only adds more mystery into these enigmatic interactions between T cells and the brain. Our results suggest that meningeal space, surrounding the brain, is the site where CNS-associated
Aging Brain Initiative Symposium: Cellular & Molecular Mechanisms of Neurodegeneration
David Atwell, Anne Brunet, Diane Chan, Don Cleveland, Marco Colonna, Valina Dawson, Myriam Heiman, Jonathan Kipnis, Lennart Mucke, Dorothy Schafer
Tue, Sep 22, 2020 · 03:00 UTC
The Aging Brain Initiative is an ambitious interdisciplinary effort by MIT focusing on understanding neurodegeneration and efforts to find hallmarks of aging, both in health and disease. The Initiative is broad, made up of scientists in several areas, including systems neuroscience, cell biology, engineering and computational biology, with core investigators from the Departments of Biology, Brain & Cognitive Sciences, Biological Engineering, and Computer Science & Artificial Intelligence Labs. "The theme of this symposium is Cellular & Molecular Mechanisms of Neurodegeneration.
Mechanisms of pathogenesis in the tauopathies
Karen Duff · UK Dementia Research Institute at UCL
Thu, Jul 23, 2020 · 15:00 UTC
The distribution of pathological tau in the brain of patients with AD is highly predicable, and as disease worsens, it spreads transynaptically from initial regions of vulnerability. The reason why only some neurons are vulnerable to the accumulation and propagation of pathological forms of tau, and the mechanisms by which tauopathy spreads through the brain are not well understood. Using a combination of immunohistochemistry and computational analysis we have examined pathway differences between vulnerable and resistant neurons. How tau spreads across a synapse has been examined in vitro usin
Understanding the altered brain metabolism and oxidative stress: Insights into metabolic syndrome and premature aging in a novel obese rodent model
Jitendra Kumar Sinha, Shampa Ghosh, Krishna Kumar Singh, Manchala Raghunath · FENS Forum 2024
The proportion of aged individuals in the general population is increasing, and non-communicable diseases like obesity are major contributors to mortality in older individuals. The WNIN/Ob obese rat exhibits a significantly reduced average lifespan of 15 months. Exploring molecular and biochemical characteristics of these rats can establish them as appropriate model for studying the neurobiology of aging and obesity.We investigated the growth characteristics and lifespan of WNIN/Obobese rats, examined neuronal-glial changes, levels of oxidative stress, antioxidant enzyme activity, and DNA dama